Tuesday, February 12, 2013

GSK, Vanderbilt partner to develop and commercialize new therapies for severe obesity

Vanderbilt University announced today that it has signed a collaboration agreement with GlaxoSmithKline (GSK) for the discovery, development and commercialization of novel therapies for severe obesity.

URL: http://www.news-medical.net/news/20130213/GSK-Vanderbilt-partner-to-develop-and-commercialize-new-therapies-for-severe-obesity.aspx

No comments:

Post a Comment